HARBOURVEST PARTNERS LLC - Q4 2015 holdings

$274 Million is the total value of HARBOURVEST PARTNERS LLC's 25 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 81.8% .

 Value Shares↓ Weighting
W SellWayfair$205,080,000
+32.5%
4,306,584
-2.4%
74.91%
+9.6%
NXPI NewNXP Semiconductors NV$16,515,000196,020
+100.0%
6.03%
ZAYO BuyZayo Group Holdings$14,222,000
+11.0%
534,867
+5.9%
5.20%
-8.2%
LC  LendingClub Corp.$11,706,000
-16.5%
1,059,3340.0%4.28%
-30.9%
SAGE SellSage Therapeutics, Inc.$6,096,000
-12.1%
104,568
-36.2%
2.23%
-27.3%
FNJN  Finjan$4,949,000
-30.3%
4,303,4350.0%1.81%
-42.4%
SUPN NewSupernus Pharmaceuticals, Inc.$3,706,000275,753
+100.0%
1.35%
RSYS NewRadiSys Corporation$1,515,000546,956
+100.0%
0.55%
SCTY  SolarCity Corporation$1,473,000
+19.5%
28,8700.0%0.54%
-1.3%
FMI  Foundation Medical, Inc.$1,191,000
+14.1%
56,5670.0%0.44%
-5.6%
ETSY NewETSY, Inc.$1,072,000129,819
+100.0%
0.39%
BNFT NewBenefitFocus, Inc.$1,049,00028,828
+100.0%
0.38%
ZLTQ NewZeltiq Aesthetics, Inc.$966,00033,862
+100.0%
0.35%
SHOP NewShopify, Inc.$927,00035,919
+100.0%
0.34%
BOX SellBox, Inc.$815,000
+2.3%
58,369
-7.9%
0.30%
-15.3%
ZFGN  Zafgen, Inc.$704,000
-80.3%
111,8940.0%0.26%
-83.7%
MESG  Xura, Inc.$436,000
+9.8%
17,7340.0%0.16%
-9.1%
ECOM  ChannelAdvisor Corporation$395,000
+39.6%
28,5120.0%0.14%
+15.2%
ATRA  Atara Biotherapeutics, Inc.$278,000
-16.0%
10,5430.0%0.10%
-30.1%
MOBL SellMobileIron, Inc.$172,000
-37.0%
47,566
-46.0%
0.06%
-47.9%
TRVN NewTrevena, Inc.$139,00013,264
+100.0%
0.05%
OPWR  OPOWER, Inc.$84,000
+18.3%
7,9390.0%0.03%0.0%
EPZM  Epizyme, Inc.$83,000
+23.9%
5,1960.0%0.03%0.0%
CMLS NewCumulus Media, Inc.$74,000223,875
+100.0%
0.03%
AXGN NewAxoGen, Inc.$70,00013,964
+100.0%
0.03%
EVDY NewEveryday Health, Inc.$60,0009,939
+100.0%
0.02%
TSRO ExitTesoro Corporation$0-1,539
-100.0%
-0.03%
PBPB ExitPotbelly Sandwich Works LLC$0-76,671
-100.0%
-0.37%
VTAE ExitVitae Pharmaceuticals$0-85,217
-100.0%
-0.41%
AWAY ExitHomeAway, Inc.$0-50,244
-100.0%
-0.59%
QLYS ExitQualys, Inc.$0-48,184
-100.0%
-0.61%
CLVS ExitClovis Oncology$0-35,618
-100.0%
-1.45%
ENVI ExitEnvivio$0-3,639,939
-100.0%
-6.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
40-APP2024-04-24
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26
13F-HR2022-05-13

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (273776000.0 != 273777000.0)
  • The reported number of holdings is incorrect (25 != 26)
  • The reported has been restated
  • The reported has been amended

Export HARBOURVEST PARTNERS LLC's holdings